Cancers that express estrogen receptor alpha (ER+ breast cancers) constitute the most plentiful subset of these cancers, and the importance of estrogenic signals in fueling tumor behavior has led to targeted therapies that are major components of standard treatments. Here, ESR1 is linked to breast cancer.